Wednesday, May 01, 2013 8:02:26 AM
April 30th, 2013 - 0 comments - Filed Under - by Trevor Kearing
Ixia (NASDAQ: XXIA) announced its earnings results on Tuesday. The company reported $0.25 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.03, ARN reports. The company had revenue of $122.80 million for the quarter, compared to the consensus estimate of $122.41 million. During the same quarter in the prior year, the company posted $0.16 earnings per share. The company’s quarterly revenue was up 41.6% on a year-over-year basis.
A number of analysts have recently weighed in on XXIA shares. Analysts at Deutsche Bank raised their price target on shares of Ixia from $18.00 to $24.00 in a research note to investors on Friday, March 8th. They now have a “buy” rating on the stock. On the ratings front, analysts at Stifel Nicolaus raised their price target on shares of Ixia to $24.00 in a research note to investors on Thursday, February 7th.
Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $21.00.
Ixia (NASDAQ: XXIA) traded up 1.98% on Tuesday, hitting $16.47. Ixia has a 52-week low of $9.95 and a 52-week high of $22.50. The stock’s 50-day moving average is currently $19.83. The company has a market cap of $1.239 billion and a price-to-earnings ratio of 27.37.
Ixia is a provider of converged test systems and services for wireless and wired infrastructures and services.
________________________________________________________
http://www.dailypolitical.com/finance/stock-market/ixia-xxia-posts-quarterly-earnings-results-beats-expectations-by-0-03-eps.htm
XXIA
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM